Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Claudia Hoyen, MD

Claudia Hoyen, MD

  • Director, Pediatric Infection Control, UH Rainbow Babies and Children's Hospital
  • Director, Pediatric Innovation, UH Rainbow Babies and Children's Hospital
  • Associate Professor, CWRU School of Medicine
  • Specialty: Pediatric Infectious Diseases
  • Location:
    UH Cleveland Medical Center Mather
    11100 Euclid Ave
    Cleveland, OH 44106

Biography: Claudia Hoyen, MD

Expertise

  • Antimicrobial Resistance
  • Colonization with Antibiotic-Resistant Pathogens
  • Infection Control
  • Molecular Epidemiology
  • Pediatric Infectious Diseases
  • Pediatric Innovation

Certifications & Memberships

  • Pediatric Infectious Diseases - American Board of Pediatrics
  • Pediatrics - American Board of Pediatrics

Education

Research Fellowship | Internal Medicine
Internal Medicine - Case Western Reserve University School Of Medicine (1999 - 2001)

Fellowship | Pediatric Infectious Diseases
Pediatric Infectious Diseases - University Hospitals Of Cleveland (1996 - 1999)

Residency | Pediatrics/Chief Resident
Pediatrics/Chief Resident - University Hospitals Of Cleveland (1995 - 1996)

Residency | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1993 - 1995)

Internship | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1992 - 1993)

Internship | Flex
Flex - Wheaton Franciscan Healthcare-St Joseph (1991 - 1992)

Medical Education
Medical College Of Wisconsin (1991)

Undergraduate
University Of Wisconsin-Milwaukee (1988)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Claudia Hoyen did not disclose any Outside Relationships with Industry.